🔴 Harmony Biosciences is trading 4.1% down in pre-market today as biotech stocks retreat

Harmony Biosciences is trading 4.1% down now at $36.50, primarily amid a biotech-sector pullback following the Moderna-fueled rally.

• The stock closed at $38.07 on August 20, 2026.
• No fresh company-specific announcement, earnings release, or regulatory event was identified for August 21.
• The XBI was reportedly down 2.5%; a mixed broader market, Thursday’s selloff, and renewed yield concerns are pressuring risk-sensitive shares.